Previous results from our group have shown that podocytes have increased expression of urokinase plasminogen activator receptor (uPAR) in situ in biopsies from adult [8] and pediatric [9] patients with morphological lesions compatible with FSGS. The gene discussed is PLAUR; the disease is focal segmental glomerulosclerosis.